Combo Bio-engineered Sirolimus Eluting Stent: Completed Phase II enrollment

OrbusNeich completed enrollment of 183 patients in the open-label, international Phase II REMEDEE trial to compare its Combo Bio-engineered stent vs. Taxus Liberte paclitaxel-eluting stent from Bost...